Esophagogastric Junction Cancer
📧 Sign up to get email alerts when something new happens for Esophagogastric Junction Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Update: Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy [Phase 2, Phase 3]
Clinical trial comparing ramucirumab plus FOLFIRI versus ramucirumab plus paclitaxel in advanced or metastatic gastric cancer after one prio…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction Cancer
A Semmelweis University study evaluating noninvasive prognostic parameters for esophageal cancer and the esophagogastric junction cancer; cu…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy [Phase 2, Phase 3]
A Phase 2/3 trial comparing ramucirumab plus FOLFIRI versus ramucirumab plus paclitaxel in patients with advanced or metastatic gastric/EGJ …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) [Phase 1]
Phase 1 study of ADP-A2M4CD8 as monotherapy or in combination with nivolumab or pembrolizumab in HLA-A2+ patients with MAGE-A4-positive tumo…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Combined Systemic and Intraperitoneal Chemotherapy for Synchronous Gastric and/or Gastroesophageal Peritoneal Carcinomatosis [Phase 2]
Phase 2 trial evaluating combined systemic and intraperitoneal chemotherapy for synchronous gastric and gastroesophageal peritoneal carcinom…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer) [Phase 2]
A Phase 2 clinical trial evaluating ONO-4578 in combination with Nivolumab and chemotherapy in chemotherapy-naïve patients with HER2-negativ…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Neoadjuvant Treatment Modalities in Esophageal Cancer [Phase 3]
Phase 3 trial update evaluating neoadjuvant treatment modalities for esophageal cancer; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer [Phase 3]
Phase 3 clinical trial evaluating chemoradiotherapy for esophageal cancer or esophagogastric junction cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors [Phase 1]
This clinical trial update describes a first-in-human Phase 1 study of an investigational therapy in adults with advanced solid tumors, incl…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM [Phase 2]
Phase 2 trial evaluating the efficacy and safety of HIPEC combined with a PD-1 inhibitor and S-1 plus oxaliplatin chemotherapy in metastatic…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer [Phase 2]
A Phase 2 trial of perioperative chemoimmunotherapy with or without preoperative chemoradiation for locally advanced gastric cancer was term…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: QL1706 Combined With SOX Used in Theperioperative Treatment [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating QL1706 in combination with the SOX chemotherapy regimen as perioperative treatment for gastric cancer …
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer
A completed clinical trial evaluating PET imaging with the radiotracer 18F-BMS-986229 in patients with cancers of the esophagus, stomach, or…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology [Phase 2]
This document reports the completion of a Phase 2 trial evaluating heated intraperitoneal chemotherapy plus gastrectomy for gastric cancer w…
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: Development of a Clinical Decision Support System With Artificial Intelligence for Cancer Care
This clinical trial update describes the development of an AI-powered Clinical Decision Support System to assist cancer care and lists gastr…
-
CLINICAL_TRIALS research · 2024-09-05Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer) [Phase 3]
This clinical trial update describes a Phase 3 study evaluating ONO-4538 (nivolumab) in combination with ipilimumab and chemotherapy for che…
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: ADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Esophageal or Esophagogastric Junction Cancers (SURPASS-2) [Phase 2]
Phase 2 SURPASS-2 trial evaluating ADP-A2M4CD8 in HLA-A2+ patients with MAGE-A4 positive esophageal or esophagogastric junction cancers was …
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Study Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer. [Phase 2]
Phase 2 study evaluating the myDIET software tool for nutritional management in patients with localized, resectable gastric or gastroesophag…
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: Perioperative Adebrelimab and Chemotherapy in Esophageal and Esophagogastric Junction Carcinoma [Phase 2]
A Phase 2 clinical trial update evaluating perioperative Adebrelimab plus chemotherapy for esophageal and esophagogastric junction carcinoma…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis [Phase 2]
Phase 2 study evaluating combined intraperitoneal/intravenous paclitaxel with oral capecitabine for gastric adenocarcinoma with peritoneal c…
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers [Phase 2]
A Phase 2 study evaluating immunotherapy in combination with chemotherapy for gastric cancer and gastroesophageal junction cancers; the tria…
-
CLINICAL_TRIALS trial_result · 2020-07-21Clinical Trial Update: Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01 [Phase 2, Phase 3]
Phase II/III study comparing chemoradiotherapy with radiotherapy in elderly patients with esophageal or esophagogastric cancer has completed…
-
CLINICAL_TRIALS trial_result · 2020-01-29Clinical Trial Update: A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy [Phase 3]
Phase 3 randomized, double-blind trial comparing paclitaxel with and without RAD001 in advanced gastric cancer after prior chemotherapy (com…
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism [Phase 2]
A Phase 2 randomized open-label study comparing subcutaneous dalteparin to direct oral anticoagulants for cancer-associated venous thromboem…
-
CLINICAL_TRIALS research · 2017-07-11Clinical Trial Update: Chemotherapy for Potentially Resectable Locally Advanced Esophagogastric Junction Carcinoma
This clinical trial update covers chemotherapy for potentially resectable locally advanced esophagogastric junction cancer, sponsored by Any…